| Factor Information | |
|---|---|
| Data ID | 35 |
| Factor | Cord blood homocysteine |
| Description | Cord blood homocysteine levels were significantly higher compared with the control group. |
| Biomarker | NA |
| Classification | E2 (physiological factor - biochemical index) |
| Association | |
|---|---|
| Application | prognosis |
| Objective | To access the predict value of cord blood homocysteine level with fetal CHD outcome. |
| p Value | 0.02 |
| Conclusion | High cord blood B-type natriuretic peptide and homocysteine levels and low cord blood folate levels at term may be useful for predicting congenital heart disease in the neonate |
| Risk Factor | unknown |
| CHD Type | |
|---|---|
| ID | 148 |
| CHD Type | NA |
| CHD Subtype | NA |
| Reference | |
|---|---|
| PMID | 31256695 |
| Year | 2019 |
| Title | Maternal and cord blood homocysteine, vitamin B12, folate, and B-type natriuretic peptide levels at term for predicting congenital heart disease of the neonate: A case-control study |
| Sample | ||
|---|---|---|
| Population | adults | |
| Source | cord blood | |
| Region | Ankara, Turkey | |
| Method | a chemiluminescent microparticle immunoassay | |
| Race | Europe | |
| Disease History | N/A | |
| Treatment History | N/A | |
| Group | group with fetal CHD(Treatment) | group without fetal CHD(Control) |
| Number | 42 | 43 |
| Age | 29.79±4.49 (19–39)years(group with fetal CHD) | 31.47±4.28 (25–41)years(group without fetal CHD) |
| Gender (Male: Female) | 0:42 | 0:43 |
| Marker Level | 6.81±1.85 (3.42–10.67)(μmol/L) | 5.89±1.65 (3.04–11.54) (μmol/L) |
